{
    "1616083426100252673": {
        "author_id": "5383942",
        "created_at": "2023-01-19T14:41:28.000Z",
        "edit_history_tweet_ids": [
            "1616083426100252673"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 67,
                    "normalized_text": "farmacovigilancia",
                    "probability": 0.5618,
                    "start": 51,
                    "type": "Other"
                },
                {
                    "end": 110,
                    "normalized_text": "Mexico",
                    "probability": 0.5134,
                    "start": 105,
                    "type": "Place"
                }
            ],
            "mentions": [
                {
                    "end": 11,
                    "id": "1046148324481470466",
                    "start": 0,
                    "username": "Cera_Zette"
                }
            ]
        },
        "id": "1616083426100252673",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 28,
            "like_count": 0,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 0
        },
        "text": "@Cera_Zette Hello - That is a valid email address (farmacovigilancia.mx@gsk.com) for one of our teams in Mexico. You can try and reach out to them via that email. However, that team may not be able to give you a product availability update."
    }
}